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Nontuberculous mycobacteria (NTM) are ubiquitous organ-
isms that are highly prevalent in the environment. The evi-
dence that these organisms originate in the environment is
overwhelming; and there is no significant evidence for ani-
mal-to-human or human-to-human transmission. NTM
were first recognized as human pathogens in 1950s [1] and
since then more than 150 NTM species have been recognized
[2]. Humans may be exposed to NTM on a regular basis
through showering, bathing, and other activities using water,
soil, or aerosols [3].How,when,why, and inwhich population
NTM infection might occur are largely unknown.
The incidence rate of NTM infections appears to have
increased during the last decade globally resulting in a
significantmortality andmorbidity [4, 5]. Studies have shown
a high incidence rate of NTM in elderly population and
increasing susceptibility in very elderly people. It has been
estimated that NTM incidence will continue to rise due to
increasing elderly population by 2050 [6]. Little is known
about the diseases caused by the NTM and only limited data
are available showing its prevalence and associated factors
[7, 8]. Bronchiectasis, chronic lung diseases, pulmonary
fibrosis, anddecreased lung immunity are someof known risk
factors for pulmonary NTM diseases. NTM disease has also
gained increasing attention in countries with high incidence
of tuberculosis due to risk of misdiagnosis with multidrug
resistant tuberculosis (MDR-TB) [9]. A recently published
study showed the frequency of NTM misdiagnosis in up to
30% of patients with suspected MDR-TB [10].
The disease caused by NTM forms a broad clinical spec-
trum from asymptomatic infection to fatal disseminated
disease in human. While many of NTM patients have under-
lying pulmonary diseases, NTM symptoms are undifferen-
tiated from symptoms of patients with chronic pulmonary
structural diseases such as bronchiectasis. Therefore, routine
screening and having high suspicion for NTM disease are
highly recommended.
Diagnosis of infection by NTM is another challenging
issue.Thediagnosis ofNTMwith conventionalmicrobiologic
methods may be misleading and molecular approaches are
advised [11].
Increased knowledge and understanding of this type of
mycobacterial disease could improve patient care of affected
persons worldwide. We also highly recommend continu-
ing translational studies to develop precision medicine in
mycobacterial diseases [12].
In this special issue, a series of original articles as well
as expert reviews on NTM are published to stimulate a
greater understanding of NTM infections. Suggested areas of
research are included: microbiologic and molecular diagnos-
tic tools, drug susceptibility tests, human genetic susceptibil-
ity, prevalence and incidence studies, clinical presentations,
and clinical trials for antibiotic therapy. We were particularly
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interested in studies describing new laboratory diagnostic
tools for NTM, modalities for clinical characterization of
NTM diseases in patients with and without underlying
diseases, and measuring outcomes of treatment trials.
In conclusion, the incidence of NTMdisease is increasing
and needs urgent attention by health policymakers and inter-
national societies. Better molecular tools for rapid diagnosis
of NTM, understanding of immunopathogenesis, and host
pathogen interactions are needed. In the last years, we have
seen an explosion inNTMresearches. Consequently, we hope
to see more publications from basic and traditional research
to answer our questions about NTM in coming years.
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